Hangzhou Nurotron Biotechnology is a high-tech enterprise providing nerve electronic products.
Hangzhou Nurotron Biotechnology Co., Ltd., (诺尔康神经电子科技) is a high-tech enterprise providing nerve electronic products. The company is mainly involved in the R&D of multipath manual electrical cochlea systems, nationalization and clinical application of auditory brainstem implant equipment, strategy and technology enhancement of home-grown manual cochlea, and more. The company’s headquarters and production base are located in Hangzhou, China, and its R&D center is located in California, USA.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 9, 2020 | Series E | $24M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Superstring Capital | — | Series E |